Popa Miruna A, Hessling Gabriele, Deisenhofer Isabel, Bourier Felix
Department of Electrophysiology, German Heart Center Munich, Technical University of Munich, Lazarettstraße 36, 80636 Munich, Germany.
Eur Heart J Case Rep. 2023 Mar 9;7(3):ytad118. doi: 10.1093/ehjcr/ytad118. eCollection 2023 Mar.
Ventricular tachycardia (VT) originating in the right ventricular outflow tract (RVOT) is the most common form of idiopathic VT. Catheter ablation of right ventricular outflow tract tachycardia (RVOT-VT) is associated with high success rates. However, non-inducibility of VT on electrophysiological (EP) study can severely impact ablation outcome. We describe a novel catheter ablation strategy which proved feasible and safe in a case of highly symptomatic, non-inducible RVOT-VT.
A 51-year-old male with a history of non-sustained VT (NSVT) was referred to our hospital after two syncopal episodes resulting in collapse. Upon admission, a cluster of monomorphic NSVT (250-270 b.p.m.) resulted in haemodynamic instability and required transfer to the intensive care unit. On twelve-lead electrocardiogram, NSVT showed inferior axis and left bundle branch block, suggestive of RVOT-VT. Diagnostic workup including echocardiography, coronary angiography, and late enhancement computed tomography (CT) revealed no evidence of structural heart disease. On two EP studies, non-inducibility of clinical VT despite repeated ventricular pacing and isoproterenol infusion rendered precise mapping of triggered activity unfeasible. Therefore, a bailout ablation strategy was developed by performing a circumferential electrical RVOT isolation using a 3.5 mm irrigated-tip ablation catheter under the guidance of high-density electroanatomic mapping (CARTO® 3) and CT reconstruction of cardiac anatomy. No procedural complications occurred, and the patient remained arrhythmia-free during a 6-month follow-up period.
Catheter ablation is a first-line therapy for symptomatic and drug-refractory idiopathic RVOT-VT. Non-inducibility of RVOT-VT represents a relevant limitation for successful ablation which might be overcome by electrical RVOT isolation as a bailout ablation strategy.
起源于右心室流出道(RVOT)的室性心动过速(VT)是特发性VT最常见的形式。右心室流出道心动过速(RVOT-VT)的导管消融成功率很高。然而,电生理(EP)研究中VT不能被诱发会严重影响消融结果。我们描述了一种新型导管消融策略,该策略在一例症状严重、不能诱发的RVOT-VT病例中被证明是可行且安全的。
一名51岁男性,有非持续性室性心动过速(NSVT)病史,在两次晕厥发作导致跌倒后被转诊至我院。入院时,一阵单形性NSVT(250-270次/分钟)导致血流动力学不稳定,需要转入重症监护病房。十二导联心电图显示,NSVT呈下轴和左束支传导阻滞,提示RVOT-VT。包括超声心动图、冠状动脉造影和延迟强化计算机断层扫描(CT)在内的诊断检查未发现结构性心脏病的证据。在两次EP研究中,尽管反复进行心室起搏和静脉滴注异丙肾上腺素,临床VT仍不能被诱发,因此无法精确标测触发活动。因此,在高密度电解剖标测(CARTO® 3)和心脏解剖CT重建的引导下,使用3.5毫米灌注尖端消融导管进行右心室流出道环形电隔离,制定了一种补救性消融策略。未发生手术并发症,患者在6个月的随访期内未再发生心律失常。
导管消融是有症状且药物难治性特发性RVOT-VT的一线治疗方法。RVOT-VT不能被诱发是成功消融的一个相关限制因素,作为一种补救性消融策略,右心室流出道电隔离可能会克服这一限制。